Research Paper Volume 13, Issue 18 pp 22109—22119

LHX9, a p53-binding protein, inhibits the progression of glioma by suppressing glycolysis

Down-regulation of LHX9 is associated with poorer survival of glioma patients. (A) GEPIA database analysis showed that LHX9 was positively correlated with survival time of patients. Patients with higher LHX9 expression levels survived better. (B, C) The expression levels of LHX9 in normal and glioma tissues were detected by Western blot, and quantified. (D) The expression levels of LHX9 in normal cells HEB and glioma cells were detected by Western blot.

Figure 1. Down-regulation of LHX9 is associated with poorer survival of glioma patients. (A) GEPIA database analysis showed that LHX9 was positively correlated with survival time of patients. Patients with higher LHX9 expression levels survived better. (B, C) The expression levels of LHX9 in normal and glioma tissues were detected by Western blot, and quantified. (D) The expression levels of LHX9 in normal cells HEB and glioma cells were detected by Western blot.